Výsledky vyhledávání

Akademický článek

Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299

Autor: Arkadiusz Z. Dudek, MD, PhD, Min X. Xi, PhD, Katherine A. Scilla, MD, Hirva Mamdani, MD, Benjamin C. Creelan, MD, Andreas Saltos, MD, Tawee Tanvetyanon, MD, Alberto Chiappori, MD

Publikováno v: JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100584- (2023)

Introduction: We hypothesized that ramucirumab could increase previously reported objective response rate (ORR) of 11% of single-agent nivolumab in the second-line therapy of unresectable mesothelioma. Methods: This was a cooperative group, single-ar

Externí odkaz: https://doaj.org/article/0149c45692094f848ef9ee464ffa82d8

Zobrazit plný text záznamu

Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes

Autor: Richard M. Bergenstal, Deborah M. Mullen, Ellie Strock, Mary L. Johnson, Min X. Xi

Publikováno v: Journal of diabetes and its complications. 36(3)

Evaluate whether structured BGM testing (BGM) or real-time CGM (CGM) lead to improved glucose control (A1c). Determine which approach optimized glucose control more effectively. METHODS-MULTI-ARM PARALLEL: trial of three type 2 diabetes (T2D) therapi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcb514c44e4e15c362c1e2f8233d5cb9
https://pubmed.ncbi.nlm.nih.gov/35131155

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání